CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.


Begin main content

Propiverine hydrochloride

Last Updated: September 9, 2016
Result type: Reports
Project Number: SR0504-000
Product Line: Reimbursement Review

Generic Name: Propiverine hydrochloride

Brand Name: Mictoryl

Manufacturer: Duchesnay Inc.

Therapeutic Area: Overactive bladder (OAB)

Indications: Overactive bladder (OAB)

Submission Type: Initial

Project Status: Complete

Date Recommendation Issued: April 19, 2017

Recommendation Type: Reimburse with clinical criteria and/or conditions